Genetic prognostic and predictive markers in colorectal cancer.

Genetic prognostic and predictive markers in colorectal cancer.

Despite many studies of the likely survival outcome of individual patients with colorectal cancer, our knowledge of this subject remains poor. Until recently, we had virtually no understanding of individual responses to therapy, but the discovery of the KRAS mutation as a marker of probable failure...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Walther, A, Johnstone, E, Swanton, C, Midgley, R, Tomlinson, I, Kerr, D
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

Erratum: Genetic prognostic and predictive markers in colorectal cancer (Nature Reviews Cancer (2009) 9 (489-499))
de réir: Walther, A, et al.
Foilsithe / Cruthaithe: (2011)

Genetic prognostic markers in colorectal cancer.
de réir: Houlston, R, et al.
Foilsithe / Cruthaithe: (1997)

Genome-wide association study for germline prognostic markers in colorectal cancer
de réir: Walther, A, et al.
Foilsithe / Cruthaithe: (2010)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
de réir: Johnstone, E, et al.
Foilsithe / Cruthaithe: (2008)

Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2010)

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2010)

Immunotherapy for colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2003)

Colorectal cancer.
de réir: Nicum, S, et al.
Foilsithe / Cruthaithe: (2003)

Colorectal cancer
de réir: Nicum, S, et al.
Foilsithe / Cruthaithe: (2003)

Chromosomal instability, colorectal cancer and taxane resistance.
de réir: Swanton, C, et al.
Foilsithe / Cruthaithe: (2006)

Effect of SNP haplotypes associated with colorectal cancer risk on outcome
de réir: Walther, A, et al.
Foilsithe / Cruthaithe: (2008)

Adjuvant therapy of colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Chemotherapy for colorectal cancer.
de réir: Nicum, S, et al.
Foilsithe / Cruthaithe: (2000)

ABC of colorectal cancer: adjuvant therapy.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Towards post-genomic investigation of colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2000)

Conventional cytotoxic and novel therapeutic concepts in colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2001)

The emergence of 'omics for the management of colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2011)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2005)

Immunotherapy for colorectal cancer: a challenge to clinical trial design.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Evolution of nonsurgical therapy for colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2009)

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
de réir: Domingo, E, et al.
Foilsithe / Cruthaithe: (2013)

Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver
de réir: Pwint, T, et al.
Foilsithe / Cruthaithe: (2010)

Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
de réir: Pwint, T, et al.
Foilsithe / Cruthaithe: (2010)

Systemic treatment of colorectal cancer.
de réir: Tebbutt, N, et al.
Foilsithe / Cruthaithe: (2002)

Is sidedness prognostically important across all stages of colorectal cancer?
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2016)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2005)

Biomarkers in early-stage colorectal cancer: ready for prime time?
de réir: Church, D, et al.
Foilsithe / Cruthaithe: (2012)

Genetic pathways in colorectal cancer.
de réir: Ilyas, M, et al.
Foilsithe / Cruthaithe: (1996)

Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer
de réir: Church, D, et al.
Foilsithe / Cruthaithe: (2013)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
de réir: V. A. Grigorenko, et al.
Foilsithe / Cruthaithe: (2021-07-01)

An update on the genetics of colorectal cancer.
de réir: Kemp, Z, et al.
Foilsithe / Cruthaithe: (2004)

Colorectal Cancer: A Multidisciplinary Approach
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2012)

GLR in Colorectal Cancers: An Easily Accessible Prognostic Marker
de réir: Aydin İC, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Colorectal cancer and genetic alterations in the Wnt pathway.
de réir: Segditsas, S, et al.
Foilsithe / Cruthaithe: (2006)

Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis.
de réir: Walther, A, et al.
Foilsithe / Cruthaithe: (2008)

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
de réir: Maughan, T, et al.
Foilsithe / Cruthaithe: (2010)

Personalising cancer medicine with prognostic markers
de réir: David J Kerr, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
de réir: Domingo, E, et al.
Foilsithe / Cruthaithe: (2018)